Cytokinetics Inc. buy JPMorgan Chase & Co.
Start price
12.05.26
/
50%
€63.94
Target price
12.05.27
€82.50
Performance (%)
-2.22%
Price
17:31
€62.52
Summary
This prediction is currently active. With a performance of -2.22%, the BUY prediction by JPMorgan_Chase___Co_ is trending in the wrong direction. This prediction currently runs until 12.05.27. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cytokinetics Inc. | -10.031% | -10.031% |
| iShares Core DAX® | 0.881% | 5.632% |
| iShares Nasdaq 100 | 2.390% | 1.571% |
| iShares Nikkei 225® | 4.269% | 2.521% |
| iShares S&P 500 | 1.171% | 2.545% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics (CYTK) had its price target raised by JPMorgan Chase & Co. from $92.00 to $97.00. They now have an "overweight" rating on the stock.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€29.00
09.06.25
09.06.25
€46.41
09.06.26
09.06.26
101.52%
10.06.26
10.06.26
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€50.50
05.09.24
05.09.24
€63.96
05.09.25
05.09.25
-9.31%
06.09.25
06.09.25
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€49.60
24.06.24
24.06.24
€60.52
24.06.25
24.06.25
-42.74%
25.06.25
25.06.25